ARL14 | ADP-ribosylation factor-like 14 | | | | | | Group enriched |
CAPN8 | Calpain 8 | Enzymes
| | | | | Tissue enriched |
CCKAR | Cholecystokinin A receptor | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
EPS8L3 | EPS8-like 3 | | | | | | Group enriched |
ITPKA | Inositol-trisphosphate 3-kinase A | Enzymes
| | | | | Group enriched |
KCNK16 | Potassium channel, subfamily K, member 16 | Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Group enriched |
KPNA7 | Karyopherin alpha 7 (importin alpha 8) | | | | | | Group enriched |
MS4A8 | Membrane-spanning 4-domains, subfamily A, member 8 | Predicted membrane proteins
| | | | | Group enriched |
PGC | Progastricsin (pepsinogen C) | Cancer-related genes Enzymes Predicted secreted proteins
| | | | | Tissue enriched |
TAAR1 | Trace amine associated receptor 1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enriched |
C2orf70 | Chromosome 2 open reading frame 70 | | | | | | Group enriched |
CELF3 | CUGBP, Elav-like family member 3 | | | | | | Group enriched |
ERN2 | Endoplasmic reticulum to nucleus signaling 2 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
FCGBP | Fc fragment of IgG binding protein | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
FSIP2 | Fibrous sheath interacting protein 2 | | | | | | Group enriched |
GPR25 | G protein-coupled receptor 25 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enriched |
IHH | Indian hedgehog | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
KRT20 | Keratin 20 | Plasma proteins
| | | | | Group enriched |
MIA | Melanoma inhibitory activity | Cancer-related genes Predicted secreted proteins
| | | | | Group enriched |
ONECUT3 | One cut homeobox 3 | Transcription factors
| | | | | Tissue enriched |
PAX6 | Paired box 6 | Disease related genes Transcription factors
| | | | | Group enriched |
SDR16C5 | Short chain dehydrogenase/reductase family 16C, member 5 | Enzymes Predicted membrane proteins
| | | | | Group enriched |
SLC9A3 | Solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SULT1B1 | Sulfotransferase family, cytosolic, 1B, member 1 | Plasma proteins
| | | | | Group enriched |
AMN | Amnion associated transmembrane protein | Disease related genes Predicted membrane proteins
| | | | | Group enriched |
ANXA10 | Annexin A10 | | | | | | Tissue enriched |
BCL2L15 | BCL2-like 15 | | | | | | Group enriched |
C12orf36 | Chromosome 12 open reading frame 36 | | | | | | Group enriched |
C1orf127 | Chromosome 1 open reading frame 127 | Predicted secreted proteins
| | | | | Group enriched |
CAPN13 | Calpain 13 | Enzymes
| | | | | Group enriched |
FAM101A | Family with sequence similarity 101, member A | | | | | | Tissue enriched |
LYPD6B | LY6/PLAUR domain containing 6B | Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Group enriched |
PIGR | Polymeric immunoglobulin receptor | Cancer-related genes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
RP11-595B24.2 | Uncharacterized protein | | | | | | Group enriched |
SST | Somatostatin | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
TMEM92 | Transmembrane protein 92 | Predicted membrane proteins
| | | | | Group enriched |
USH1C | Usher syndrome 1C (autosomal recessive, severe) | Cancer-related genes Cytoskeleton related proteins Disease related genes
| | | | | Group enriched |
AC079602.1 | | | | | | | Tissue enhanced |
ACER2 | Alkaline ceramidase 2 | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
ADAM28 | ADAM metallopeptidase domain 28 | Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
AGR2 | Anterior gradient 2 | Predicted secreted proteins
| | | | | Tissue enhanced |
AKR1B10 | Aldo-keto reductase family 1, member B10 (aldose reductase) | | | | | | Tissue enhanced |
AKR1B15 | Aldo-keto reductase family 1, member B15 | | | | | | Tissue enhanced |
ALDH3A1 | Aldehyde dehydrogenase 3 family, member A1 | Enzymes
| | | | | Tissue enhanced |
ANKRD22 | Ankyrin repeat domain 22 | | | | | | Tissue enhanced |
B3GNT6 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase) | Predicted secreted proteins
| | | | | Tissue enhanced |
B4GALNT3 | Beta-1,4-N-acetyl-galactosaminyl transferase 3 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
BCAS1 | Breast carcinoma amplified sequence 1 | | | | | | Tissue enhanced |
BPIFB1 | BPI fold containing family B, member 1 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
C10orf129 | Chromosome 10 open reading frame 129 | Enzymes Mitochondrial proteins Predicted membrane proteins
| | | | | Tissue enhanced |